A Multicenter Study of the Efficacy & Safety of JZP-258 in the Treatment

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04026958` - Clarithromycin Mechanisms in Hypersomnia Syndromes	Phase 2
Completed	`NCT02512588` - A Study of Safety and Efficacy of BTD-001 in Treatment of Patients With Idiopathic Hypersomnia (IH) or Narcolepsy Type 2	Phase 2
Completed	`NCT01183312` - Flumazenil for the Treatment of Primary Hypersomnia	Phase 1/Phase 2
Completed	`NCT03597555` - Sodium Oxybate in Idiopathic Hypersomnia	Phase 2/Phase 3
Completed	`NCT03356938` - The Role of the Circadian System in Neurological Sleep-wake Disorders	N/A
Active, not recruiting	`NCT03542851` - A Study of Oral BTD-001 in Adults With Idiopathic Hypersomnia	Phase 2
Completed	`NCT05156047` - A Phase 3 Study to Assess the Safety and Efficacy of Pitolisant in Adult Patients With Idiopathic Hypersomnia	Phase 3
Enrolling by invitation	`NCT05371483` - Cardiovascular and Cognitive Implications of Central Disorders of Hypersomnolence and Their Treatments
Not yet recruiting	`NCT06252571` - a Chronobiological Treatment Combining Evening Melatonin and Morning Light Therapy in Idiopathic Hypersomnia: a Prospective, Double Bind, Randomized, Placebo-controlled -Trial	Phase 2
Completed	`NCT04827329` - Anesthetic Management of Patients With Chronic Sleep Disorders
Not yet recruiting	`NCT06457945` - Mind-wandering and Predictive Processes in Narcolepsy: a Putative Mechanism Through Covert REM Intrusions	N/A
Recruiting	`NCT05875974` - Ph4 PSG Combined JZP258-407	Phase 4
Recruiting	`NCT01793168` - Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Completed	`NCT01146600` - Clarithromycin for the Treatment of Hypersomnia	Phase 2
Recruiting	`NCT04330963` - International Swiss Primary Hypersomnolence and Narcolepsy Cohort Study
Completed	`NCT04091438` - A Study of a Single Intravenous Infusion Dose of TAK-925 in Participants With Idiopathic Hypersomnia	Phase 1
Recruiting	`NCT05615584` - Spectrometry (MRM) Versus I 125 Radioimmunoassay (RIA) for Quantification of Orexin-A of Patients With Hypersomnolence	N/A
Recruiting	`NCT05837091` - Low Sodium Oxybate in Patients With Idiopathic Hypersomnia	Phase 4
Recruiting	`NCT05321355` - Mainz Register of Patients With Sleep Disorders
Active, not recruiting	`NCT05668754` - Placebo-Controlled, Double-Blind, Study to Determine the Safety and Efficacy of SDX in Patients With IH	Phase 2

NCT number	NCT03533114
Study type	Interventional
Source	Jazz Pharmaceuticals
Contact
Status	Completed
Phase	Phase 3
Start date	November 27, 2018
Completion date	December 18, 2020

A Multicenter Study of the Efficacy and Safety of JZP-258 in the Treatment of Idiopathic Hypersomnia (IH) With an Open-label Safety Extension

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms